Last reviewed · How we verify
NCT03652103
Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy
Phase 4 trial testing Ultrasound Guided Erector Spinae Plane Block Catheterisation in Nephrolithotomy, Percutaneous in 64 participants. Completed in 15 March 2019.
10 March 2019
Quick facts
| Lead sponsor | Bozyaka Training and Research Hospital |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 64 |
| Start date | 5 September 2018 |
| Primary completion | 10 March 2019 |
| Estimated completion | 15 March 2019 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Ultrasound Guided Erector Spinae Plane Block Catheterisation
- Bupivacaine 0.25% Injectable Solution — full drug profile →
Conditions studied
- Nephrolithotomy, Percutaneous — all drugs for Nephrolithotomy, Percutaneous →
- Anesthetics, Local — all drugs for Anesthetics, Local →
- Nerve Block — all drugs for Nerve Block →
- Erector Spinae Plane Block — all drugs for Erector Spinae Plane Block →
Sponsor
Bozyaka Training and Research Hospital
Who can join
18 and older, any sex, with Nephrolithotomy, Percutaneous or Anesthetics, Local. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Investigators' goal is to determine whether Erector Spinae Plane Block would provide a better analgesia, help mobilization and early discharge or increase satisfaction for patients undergoing Percutaneous Nephrolithotomy(PNL). One of the two groups will receive ESP catheterization after general anesthesia conducted. The other group will receive routine analgesia protocol used for PNL. The total amount of drugs administered, pain scores(NRS) at certain time intervals and at certain events(removal of nephrostomy and pain at mobilization) will be recorded and compared.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03652103
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nephrolithotomy, Percutaneous
Currently open trials in the same condition.
- NCT05024344 — ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy · NA · recruiting
Other Bozyaka Training and Research Hospital trials
Trials by the same sponsor.
- NCT06996977 — Menstrual Cycle and Postanesthetic Shivering · not yet recruiting
- NCT06984653 — Effect of Scalp Block on Bispectral Index Values During Skull Pinning · completed
- NCT06759506 — Can Perfusion Index and Cerebral Oxygen Saturation Trends Predict Low Cardiac Output in Pediatric Cardiovascular Surgeri · not yet recruiting
- NCT06430918 — Neuropathic Pain and it's Relation to Sleep Quality in Knee Osteoarthritis · enrolling by invitation
- NCT06029413 — Myo vs. Myofascial Injection for Myofascial Trigger Points · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03652103 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bozyaka Training and Research Hospital
- Last refreshed: 23 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03652103.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing